Terms: = Uterine cancer AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB AND Diagnosis
28 results:
1. Detection of driver mutations and genomic signatures in endometrial cancers using artificial intelligence algorithms.
Stan A; Bosart K; Kaur M; Vo M; Escorcia W; Yoder RJ; Bouley RA; Petreaca RC
PLoS One; 2024; 19(2):e0299114. PubMed ID: 38408048
[TBL] [Abstract] [Full Text] [Related]
2. Endometrial/Endometrioid Stromal Tumors With Extensive Whorling and ctnnb1 Translocation : A Report of 3 Cases.
Boyraz B; da Cruz Paula A; Deveraux KA; Tran I; da Silva EM; Young RH; Snuderl M; Weigelt B; Oliva E
Am J Surg Pathol; 2023 Nov; 47(11):1285-1290. PubMed ID: 37584555
[TBL] [Abstract] [Full Text] [Related]
3. Proteogenomic insights suggest druggable pathways in endometrial carcinoma.
Dou Y; Katsnelson L; Gritsenko MA; Hu Y; Reva B; Hong R; Wang YT; Kolodziejczak I; Lu RJ; Tsai CF; Bu W; Liu W; Guo X; An E; Arend RC; Bavarva J; Chen L; Chu RK; Czekański A; Davoli T; Demicco EG; DeLair D; Devereaux K; Dhanasekaran SM; Dottino P; Dover B; Fillmore TL; Foxall M; Hermann CE; Hiltke T; Hostetter G; Jędryka M; Jewell SD; Johnson I; Kahn AG; Ku AT; Kumar-Sinha C; Kurzawa P; Lazar AJ; Lazcano R; Lei JT; Li Y; Liao Y; Lih TM; Lin TT; Martignetti JA; Masand RP; Matkowski R; McKerrow W; Mesri M; Monroe ME; Moon J; Moore RJ; Nestor MD; Newton C; Omelchenko T; Omenn GS; Payne SH; Petyuk VA; Robles AI; Rodriguez H; Ruggles KV; Rykunov D; Savage SR; Schepmoes AA; Shi T; Shi Z; Tan J; Taylor M; Thiagarajan M; Wang JM; Weitz KK; Wen B; Williams CM; Wu Y; Wyczalkowski MA; Yi X; Zhang X; Zhao R; Mutch D; Chinnaiyan AM; Smith RD; Nesvizhskii AI; Wang P; Wiznerowicz M; Ding L; Mani DR; Zhang H; Anderson ML; Rodland KD; Zhang B; Liu T; Fenyö D;
Cancer Cell; 2023 Sep; 41(9):1586-1605.e15. PubMed ID: 37567170
[TBL] [Abstract] [Full Text] [Related]
4. uterine MEIS1::NCOA2 Fusion Sarcoma With Lung Metastasis: A Case Report and Review of the Literature.
Xing D; Meyer CF; Gross JM; Argani P; Hung CF; Wu TC; Vang R; Armstrong DK; Gaillard SL
Int J Gynecol Pathol; 2024 Jan; 43(1):47-55. PubMed ID: 37043646
[TBL] [Abstract] [Full Text] [Related]
5. Corded and Hyalinized and Spindled Endometrioid Endometrial Carcinoma: A Clinicopathologic and Molecular Analysis of 9 Tumors Based on the TCGA Classifier.
Safdar NS; Thompson EF; Gilks CB; Isacson C; Bennett JA; Clarke B; Young RH; Oliva E
Am J Surg Pathol; 2021 Aug; 45(8):1038-1046. PubMed ID: 34115671
[TBL] [Abstract] [Full Text] [Related]
6. Atypical Endometrial Hyperplasia, Low-grade: "Much ADO About Nothing".
D'Angelo E; Espinosa I; Cipriani V; Szafranska J; Barbareschi M; Prat J
Am J Surg Pathol; 2021 Jul; 45(7):988-996. PubMed ID: 34105519
[TBL] [Abstract] [Full Text] [Related]
7. FIGO Grade 3 Endometrioid Adenocarcinomas With Diffusely Aberrant β-Catenin Expression: An Aggressive Subset Resembling Cutaneous Pilomatrix Carcinomas.
Weisman P; Park KJ; Xu J
Int J Gynecol Pathol; 2022 Mar; 41(2):126-131. PubMed ID: 33811207
[TBL] [Abstract] [Full Text] [Related]
8. Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome.
Hollis RL; Thomson JP; Stanley B; Churchman M; Meynert AM; Rye T; Bartos C; Iida Y; Croy I; Mackean M; Nussey F; Okamoto A; Semple CA; Gourley C; Herrington CS
Nat Commun; 2020 Oct; 11(1):4995. PubMed ID: 33020491
[TBL] [Abstract] [Full Text] [Related]
9. Corded and Hyalinized Endometrioid Adenocarcinoma (CHEC) of the uterine Corpus are Characterized by ctnnb1 Mutations and Can Show Adverse Clinical Outcomes.
Ladwig NR; Umetsu SE; Zaloudek C; Rabban J; Garg K
Int J Gynecol Pathol; 2021 Mar; 40(2):103-115. PubMed ID: 32909971
[TBL] [Abstract] [Full Text] [Related]
10. Next-generation sequencing analysis of endometrial screening liquid-based cytology specimens: a comparative study to tissue specimens.
Akahane T; Kitazono I; Yanazume S; Kamio M; Togami S; Sakamoto I; Nohara S; Yokoyama S; Kobayashi H; Hiraki T; Suzuki S; Ueno S; Tanimoto A
BMC Med Genomics; 2020 Jul; 13(1):101. PubMed ID: 32652986
[TBL] [Abstract] [Full Text] [Related]
11. Identification of a Gene Panel for Endometrioid Endometrial cancer: a Possible Prognostic Value?
Malentacchi F; Turrini I; Sorbi F; Projetto E; Castiglione F; Vergoni F; Amunni G; Fambrini M; Petraglia F; Noci I; Pillozzi S
Reprod Sci; 2020 Feb; 27(2):592-598. PubMed ID: 32046431
[TBL] [Abstract] [Full Text] [Related]
12. Immunophenotype of Atypical Polypoid Adenomyoma of the Uterus: Diagnostic Value and Insight on Pathogenesis.
Travaglino A; Raffone A; Saccone G; Fuggi M; De Placido G; Mascolo M; Mollo A; Insabato L; Zullo F
Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):646-653. PubMed ID: 31855579
[TBL] [Abstract] [Full Text] [Related]
13. Practical roles for molecular diagnostic testing in ovarian adult granulosa cell tumour, Sertoli-Leydig cell tumour, microcystic stromal tumour and their mimics.
Rabban JT; Karnezis AN; Devine WP
Histopathology; 2020 Jan; 76(1):11-24. PubMed ID: 31846522
[TBL] [Abstract] [Full Text] [Related]
14. Mesonephric-like Carcinoma of the Endometrium: A Subset of Endometrial Carcinoma With an Aggressive Behavior.
Euscher ED; Bassett R; Duose DY; Lan C; Wistuba I; Ramondetta L; Ramalingam P; Malpica A
Am J Surg Pathol; 2020 Apr; 44(4):429-443. PubMed ID: 31725471
[TBL] [Abstract] [Full Text] [Related]
15. Mesonephric adenocarcinoma of the cervix: a case report with a three-year follow-up, lung metastases, and next-generation sequencing analysis.
Montalvo N; Redrobán L; Galarza D
Diagn Pathol; 2019 Jul; 14(1):71. PubMed ID: 31266530
[TBL] [Abstract] [Full Text] [Related]
16. Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma.
Cuevas D; Valls J; Gatius S; Roman-Canal B; Estaran E; Dorca E; Santacana M; Vaquero M; Eritja N; Velasco A; Matias-Guiu X
Virchows Arch; 2019 May; 474(5):585-598. PubMed ID: 30710169
[TBL] [Abstract] [Full Text] [Related]
17. Clinicopathologic and Immunohistochemical Correlates of ctnnb1 Mutated Endometrial Endometrioid Carcinoma.
Costigan DC; Dong F; Nucci MR; Howitt BE
Int J Gynecol Pathol; 2020 Mar; 39(2):119-127. PubMed ID: 30702464
[TBL] [Abstract] [Full Text] [Related]
18. Multiclonality and Marked Branched Evolution of Low-Grade Endometrioid Endometrial Carcinoma.
Lazo de la Vega L; Samaha MC; Hu K; Bick NR; Siddiqui J; Hovelson DH; Liu CJ; Carter CS; Cho KR; Sciallis AP; Tomlins SA
Mol Cancer Res; 2019 Mar; 17(3):731-740. PubMed ID: 30610106
[TBL] [Abstract] [Full Text] [Related]
19. Efficacy of liquid-based genetic diagnosis of endometrial cancer.
Matsuura M; Yamaguchi K; Tamate M; Satohisa S; Teramoto M; Iwasaki M; Sugita S; Hasegawa T; Koubo R; Takane K; Ikenoue T; Furukawa Y; Saito T
Cancer Sci; 2018 Dec; 109(12):4025-4032. PubMed ID: 30289582
[TBL] [Abstract] [Full Text] [Related]
20. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
Rambau PF; McIntyre JB; Taylor J; Lee S; Ogilvie T; Sienko A; Morris D; Duggan MA; McCluggage WG; Köbel M
Am J Surg Pathol; 2017 May; 41(5):685-695. PubMed ID: 28125452
[TBL] [Abstract] [Full Text] [Related]
[Next]
